Decreased expression of DNAM‐1 on NK cells from acute myeloid leukemia patients
B Sanchez‐Correa, I Gayoso… - Immunology and cell …, 2012 - Wiley Online Library
This study tested the hypothesis that the expression of CD112 and CD155 (DNAM‐1
ligands) on leukemic blasts induces a decreased expression of the activating receptor …
ligands) on leukemic blasts induces a decreased expression of the activating receptor …
[PDF][PDF] The Difference in Initial Leukocyte Count, Bone Marrow Blast Cell Count and CD 34 Expression in Patients with Acute Myeloid Leukemia with and without …
P Notopuro, H Notopuro, I Budiwijono, P AdiPireno - مجله ی خون و سرطان ایران, 2017 - ijbc.ir
Background: Mutation in NPM1 gene has been reported to be the most common genetic
mutation in de novo acute myeloid leukemia (AML). AML with NPM1 gene mutation usually …
mutation in de novo acute myeloid leukemia (AML). AML with NPM1 gene mutation usually …
[PDF][PDF] Iranian Journal of Blood & Cancer
NP Budiono, N Jusak, N Harianto - Age (yr) - sid.ir
Background: FLT3 gene mutation contributes worse prognosis in patients with acute myeloid
leukemia (AML). Almost 67% of patients with AML with FLT3 gene mutation cannot reach …
leukemia (AML). Almost 67% of patients with AML with FLT3 gene mutation cannot reach …